VITAMINE B12 BIO
Food supplement declared in France, declaration No 2020-4-517, decision dated 15 April 2020
VITAMINE B12 BIO, from BIOCYTE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Lentinula edodes(Berk.) 26.25 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- BIOCYTE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé par jour le matin
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
Declaration 217575, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Lentinula edodes(Berk.) Pegler | Fruiting body | Dry aqueous extract | 26.25 mg |
Additives
E414
Other ingredients
Extrait de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux femmes enceintes et allaitantes, et aux enfants sans avis d’un professionnel de santé.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “VITAMINE B12 BIO: composition and regulation”, https://compoatlas.com/en/supplements/products/217575-vitamine-b12-bio, updated 15 November 2026.